Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Attorneys, Insurers Disagree With Manufacturers On Need For Clinical Evidence For MCIT Coverage
CMS says in its MCIT proposal that there’s no obligation for clinical studies, but AHIP is concerned about “clinical appropriateness” of devices
Nov 12 2020
•
By
Sue Darcey
More from Policy & Regulation
More from Medtech Insight